Back
OmniTek Engineering 10K Form
Sell
10
OMTK
OmniTek Engineering
Last Price:
$0.01
Seasonality Move:
-7.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-05-14 | 10Q | OMTK/OmniTek Engineering Quarterly |
2020-04-23 | 10K | OMTK/OmniTek Engineering Annual |
2019-11-13 | 10Q | OMTK/OmniTek Engineering Quarterly |
2019-08-19 | 10Q | OMTK/OmniTek Engineering Quarterly |
2019-05-14 | 10Q | OMTK/OmniTek Engineering Quarterly |
2019-04-01 | 10K | OMTK/OmniTek Engineering Annual |
Receive OMTK News And Ratings
See the #1 stock for the next 7 days that we like better than OMTK
OMTK Financial Statistics
Sales & Book Value
Annual Sales: | $1M |
---|---|
Cash Flow: | $-109.1K |
Price / Cash Flow: | 17.56 |
Annual Sales: | $-0.06 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -0.00640 |
---|---|
Net Income (TTM): | $-127.3K |
Gross Margin: | $457.9K |
Return on Equity: | 0% |
Return on Assets: | -13.21% |
OmniTek Engineering Earnings Forecast
Key OmniTek Engineering Financial Ratios
-
The Gross Profit Margin over the past 16 years for OMTK is 44.90%.
-
The Selling, General & Administrative Expenses for OMTK have been equal to 52.24% of Gross Profit Margin.
-
The Research & Development expenses have been 6.90% of Revenue.
-
The Net Earning history of OMTK is -16.39% of Total Revenues.
-
Per Share Earnings over the last 16 years have been positive in 9 years.
OmniTek Engineering Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Automobile Components |
Sector: | Consumer Discretionary |
Current Symbol: | OMTK |
Website: | omnitekcorp.com |
Debt
Debt-to-Equity Ratio: | -0.22 |
---|---|
Current Ratio: | 0.39 |
Quick Ratio: | 0.03 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
OMTK Technical Analysis vs Fundamental Analysis
Sell
10
OmniTek Engineering (OMTK)
is a Sell
Is OmniTek Engineering a Buy or a Sell?
-
OmniTek Engineering stock is rated a SellThe current OmniTek Engineering [OMTK] share price is $0.01. The Score for OMTK is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.